Enigma negatively regulates p53 through MDM2 and promotes tumor cell survival in mice.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Clinical Investigation

• Publication date

  2010-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI42674PMID 21060154PMCID PMC2993588
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nucleocytoplasmic functions of the PDZ‐LIM protein family: new insights into organ development

  2010cited by this paper
• Modes of p53 regulation.

  2009cited by this paper
• ATM activates p53 by regulating MDM2 oligomerization and E3 processivity

  2009cited by this paper
• ATM activates p 53 by regulating MDM 2 oligomerization and E 3 processivity

  2009cited by this paper
• Identification of brain- and bone-specific breast cancer metastasis genes.

  2009cited by this paper
• MicroRNA-125b is a novel negative regulator of p53.

  2009cited by this paper
• Egr‐1 and serum response factor are involved in growth factors‐ and serum‐mediated induction of E2‐EPF UCP expression that regulates the VHL‐HIF pathway

  2008cited by this paper
• Mdm2 and Mdm4 Loss Regulates Distinct p53 Activities

  2008cited by this paper
• Quantitative analyses reveal the importance of regulated Hdmx degradation for P53 activation

  2007cited by this paper
• The Mdm2 RING domain C‐terminus is required for supramolecular assembly and ubiquitin ligase activity

  2007cited by this paper
• An essential function of the extreme C‐terminus of MDM2 can be provided by MDMX

  2007cited by this paper
• Coping with stress: multiple ways to activate p53

  2007cited by this paper
• Expression of the serum response factor in hepatocellular carcinoma: implications for epithelial-mesenchymal transition.

  2007cited by this paper
• KCNE2, a down-regulated gene identified by in silico analysis, suppressed proliferation of gastric cancer cells.

  2007cited by this paper
• Intrinsic ubiquitination activity of PCAF controls the stability of the oncoprotein Hdm2

  2007cited by this paper
• Serum response factor micromanaging cardiogenesis.

  2007cited by this paper
• Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation.

  2007cited by this paper
• Regulating the p53 pathway: in vitro hypotheses, in vivo veritas

  2006cited by this paper
• Adenovirus‐mediated transfer of siRNA against PTTG1 inhibits liver cancer cell growth in vitro and in vivo

  2006cited by this paper
• Tumor suppression and normal aging in mice with constitutively high p53 activity.

  2006cited by this paper
• LIM Mineralization Protein-1 Potentiates Bone Morphogenetic Protein Responsiveness via a Novel Interaction with Smurf1 Resulting in Decreased Ubiquitination of Smads*

  2006cited by this paper
• E2-EPF UCP targets pVHL for degradation and associates with tumor growth and metastasis

  2006cited by this paper
• KCNE 2 , a down-regulated gene identified by in silico analysis , suppressed proliferation of gastric cancer cells

  2006cited by this paper
• Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4

  2006cited by this paper
• Hdm2 Nuclear Export, Regulated by Insulin-like Growth Factor-I/MAPK/p90Rsk Signaling, Mediates the Transformation of Human Cells*

  2006cited by this paper
• Dual-site regulation of MDM2 E3-ubiquitin ligase activity.

  2006cited by this paper
• Enigma interacts with adaptor protein with PH and SH2 domains to control insulin-induced actin cytoskeleton remodeling and glucose transporter 4 translocation.

  2006cited by this paper
• HDM2 phosphorylation by MAPKAP kinase 2

  2005cited by this paper
• Mdm2 in growth signaling and cancer

  2005cited by this paper
• MDM2 and prognosis.

  2004cited by this paper
• Stabilization of Mdm2 via Decreased Ubiquitination Is Mediated by Protein Kinase B/Akt-dependent Phosphorylation*

  2004cited by this paper
• Accelerated MDM2 auto‐degradation induced by DNA‐damage kinases is required for p53 activation

  2004cited by this paper
• A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans.

  2004cited by this paper
• The p53-Mdm2 module and the ubiquitin system.

  2003cited by this paper
• HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53

  2003cited by this paper
• p53-independent functions of MDM2.

  2003cited by this paper
• E2F and Ras Synergize in Transcriptionally Activating p14ARF Expression

  2003cited by this paper
• Mono- Versus Polyubiquitination: Differential Control of p53 Fate by Mdm2

  2003cited by this paper
• Nuclear degradation of p53 occurs during down‐regulation of the p53 response after DNA damage

  2002cited by this paper
• Serum response factor: discovery, biochemistry, biological roles and implications for tissue injury healing.

  2002cited by this paper
• Phosphorylation of HDM2 by Akt

  2002cited by this paper
• A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus

  2001cited by this paper
• Cocompartmentalization of p53 and Mdm2 is a major determinant for Mdm2-mediated degradation of p53.

  2001cited by this paper
• ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage.

  2001cited by this paper
• The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-of-function on cell growth.

  2001cited by this paper
• HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation

  2001cited by this paper
• The LIM domain: regulation by association.

  2000cited by this paper
• Protein expression of MDM2 and its clinicopathological relationships in human hepatocellular carcinoma.

  2000cited by this paper
• Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase

  2000cited by this paper
• Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome.

  2000cited by this paper
• Mdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53*

  2000cited by this paper
• Surfing the p53 network

  2000cited by this paper
• P53-protein accumulation and MDM2-protein overexpression in gastric carcinomas. No apparent correlation with survival.

  1999cited by this paper
• The PDZ domain of the LIM protein enigma binds to beta-tropomyosin.

  1999cited by this paper
• Adenovirus-mediated p53 tumor suppressor gene therapy against subcutaneous HuH7 hepatoma cell line nodule of nude mice.

  1999cited by this paper
• The PDZ Domain of the LIM Protein Enigma Binds to β-Tropomyosin

  1999cited by this paper
• Shc and Enigma Are Both Required for Mitogenic Signaling by Ret/ptc2

  1998cited by this paper
• Nucleo‐cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein

  1998cited by this paper
• Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members.

  1998cited by this paper
• The MDM2 gene amplification database.

  1998cited by this paper
• Bloom's and Werner's syndrome genes suppress hyperrecombination in yeast sgs1 mutant: implication for genomic instability in human diseases.

  1998cited by this paper
• Regulation of p53 stability by Mdm2

  1997cited by this paper
• Mdm2 promotes the rapid degradation of p53

  1997cited by this paper
• Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53

  1997cited by this paper
• A MOLECULAR AND IMMUNOHISTOCHEMICAL STUDY OF THE MDM2 PROTEIN ISOFORMS AND p53 GENE PRODUCT IN BRONCHOGENIC CARCINOMA

  1996cited by this paper
• Protein-Protein Interaction of Zinc Finger LIM Domains with Protein Kinase C*

  1996cited by this paper
• Specificity of LIM Domain Interactions with Receptor Tyrosine Kinases*

  1996cited by this paper
• Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53

  1995cited by this paper
• Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53

  1995cited by this paper
• Induction of liver growth in normal mice by infusion of hepatocyte growth factor/scatter factor.

  1995cited by this paper
• Altered patterns of MDM2 and TP53 expression in human bladder cancer.

  1994cited by this paper
• Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo.

  1994cited by this paper
• The p53-mdm-2 autoregulatory feedback loop.

  1993cited by this paper
• Mapping of the p53 and mdm-2 interaction domains.

  1993cited by this paper
• mdm2 expression is induced by wild type p53 activity.

  1993cited by this paper
• WAF1, a potential mediator of p53 tumor suppression.

  1993cited by this paper
• The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.

  1992cited by this paper

• Exploring of bladder cancer immune-related genes and potential therapeutic targets based on transcriptomic data and Mendelian randomization analysis

  2025cites this paper
• Activated Fibroblast Growth Factor Receptor 1 Mitigated Poly-PR-Induced Oxidative Stress and Protein Translational Impairment.

  2025cites this paper
• OGA mutant aberrantly hydrolyzes O-GlcNAc modification from PDLIM7 to modulate p53 and cytoskeleton in promoting cancer cell malignancy

  2024cites this paper
• MDM2: current research status and prospects of tumor treatment

  2024cites this paper
• ESF1 positively regulates MDM2 and promotes tumorigenesis.

  2024cites this paper
• Neuroprotective effects of activated fibroblast growth factor receptor 1 via the suppression of p53 accumulation against poly-PR-mediated toxicity.

  2024cites this paper
• The RNA binding protein RALY suppresses p53 activity and promotes lung tumorigenesis.

  2023cites this paper
• Cancer-derived mutation in the OGA stalk domain promotes cell malignancy through dysregulating PDLIM7 and p53

  2023cites this paper
• Regulatory and Interacting Partners of PDLIM7 in Thyroid Cancer

  2023influential citation
• PDZ and LIM Domain-Encoding Genes: Their Role in Cancer Development

  2023cites this paper
• The unexpected versatility of ALP/Enigma family proteins

  2022cites this paper
• MDM2 induces EMT via the B-Raf signaling pathway through 14-3-3

  2021cites this paper
• FGF/FGFR-Dependent Molecular Mechanisms Underlying Anti-Cancer Drug Resistance

  2021cites this paper
• Isoforms of the p53 Family and Gastric Cancer: A Ménage à Trois for an Unfinished Affair

  2021cites this paper
• Proteomic Signatures of Diffuse and Intestinal Subtypes of Gastric Cancer

  2021cites this paper
• NEW INSIGHTS INTO PTH AND CALCIUM RECEPTOR SIGNALING Is Urinary Calcium the Only Predictor of Nephrolithiasis in Patients with Asymptomatic Primary Hyperparathyroidism?

  2020cites this paper
• Functional roles of E3 ubiquitin ligases in gastric cancer

  2020cites this paper
• DNA methylation modifier LSH inhibits p53 ubiquitination and transactivates p53 to promote lipid metabolism

  2019cites this paper
• Stabilization of E2-EPF UCP protein is implicated in hepatitis B virus-associated hepatocellular carcinoma progression

  2019cites this paper
• Afadin cooperates with Claudin-2 to promote breast cancer metastasis

  2019cites this paper
• Prognostic value of the PDLIM family in acute myeloid leukemia.

  2019cites this paper
• DNA replication in progenitor cells and epithelial regeneration after lung injury requires the oncoprotein MDM2.

  2019cites this paper
• The Extracts from Allium hookeri induces p53-independent Apoptosis through Mitochondrial Intrinsic Pathways in AGS Human Gastric Carcinoma Cells

  2018cites this paper
• The RNA binding protein PTBP1 is necessary for B cell selection in germinal centers

  2018cites this paper
• MDM2-p53 Interactions in Human Hepatocellular Carcinoma: What Is the Role of Nutlins and New Therapeutic Options?

  2018cites this paper
• Enigma Plays Roles in Survival of Thyroid Carcinoma Cells through PI3K/AKT Signaling and Survivin

  2018cites this paper
• PDLIM7 and CDH18 regulate the turnover of MDM2 during CDK4/6 inhibitor therapy-induced senescence

  2018cites this paper
• IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner

  2018cites this paper
• MDM 2p 53 Interactions in Human Hepatocellular Carcinoma : What Is the Role of Nutlins and New Therapeutic Options ?

  2018cites this paper
• RAD GTPASE: IDENTIFICATION OF NOVEL REGULATORY MECHANISMS AND A NEW FUNCTION IN MODULATION OF BONE DENSITY AND MARROW ADIPOSITY

  2017influential citation
• Pathologic significance of a novel oncoprotein in thyroid cancer progression

  2017cites this paper
• The prognostic utility of the transcription factor SRF in docetaxel-resistant prostate cancer: in-vitro discovery and in-vivo validation

  2017cites this paper
• Identification and functional analysis of molecular interaction partners of δ-protocadherin family members with putative roles in cancer

  2016cites this paper
• MDM2 Increases Drug Resistance in Cancer Cells by Inducing EMT Independent of p53.

  2016cites this paper
• The Extract from Artemisia annua Linné. Induces p53-independent Apoptosis through Mitochondrial Signaling Pathway in A549 Lung Cancer Cells

  2016cites this paper
• Scaffold protein FHL2 facilitates MDM2-mediated degradation of IER3 to regulate proliferation of cervical cancer cells

  2016cites this paper
• MDM2 turnover and expression of ATRX determine the choice between quiescence and senescence in response to CDK4 inhibition

  2015cites this paper
• Targeting MDM2-p53 interaction for cancer therapy: are we there yet?

  2014cites this paper
• Quantification of Pancreatic Cancer Proteome and Phosphorylome: Indicates Molecular Events Likely Contributing to Cancer and Activity of Drug Targets

  2014cites this paper
• MDM2-p53 pathway in hepatocellular carcinoma.

  2014cites this paper
• MDM2’s social network

  2014cites this paper
• p53 in Head and Neck Cancer

  2014cites this paper
• SRF is essential for mesodermal cell migration during elongation of the embryonic body axis.

  2014cites this paper
• Enigma Prevents Cbl-c-Mediated Ubiquitination and Degradation of RETMEN2A

  2014cites this paper
• Restoration of wild-type p53 in drug-resistant mouse breast cancer cells leads to differential gene expression, but is not sufficient to overcome the malignant phenotype

  2013cites this paper
• RBB, a novel transcription repressor, represses the transcription of HDM2 oncogene

  2013cites this paper
• Endoplasmic Reticulum stress induces hepatic stellate cell apoptosis and contributes to fibrosis resolution

  2012cites this paper
• Met acts through Abl to regulate p53 transcriptional outcomes and cell survival in the developing liver.

  2012cites this paper
• The Many Faces of MDM2 Binding Partners.

  2012cites this paper
• Natural product MDM2 inhibitors: anticancer activity and mechanisms of action.

  2012cites this paper
• p63 the guardian of human reproduction

  2012cites this paper
• Dietary Lysine Imbalance Affects Muscle Proteome in Zebrafish (Danio rerio): A Comparative 2D-DIGE Study

  2012cites this paper
• Association between MDM2 promoter SNP309 T/G polymorphism and liver cancer risk - a meta-analysis.

  2012cites this paper
• Migration of Mesodermal Cells and Axial Elongation in Mouse Embryos Depend on the Serum Response Factor

  2012cites this paper
• High-Resolution Transcriptome of Human Macrophages

  2012cites this paper
• MOLECULAR STUDIES ON LIM-DOMAIN PROTEIN CRP1 PÄIVI JÄRVINEN MOLECULAR CANCER BIOLOGY PROGRAM, BIOMEDICUM HELSINKI DEPARTMENT OF VIROLOGY, HAARTMAN INSTITUTE AND GRADUATE SCHOOL OF BIOTECHNOLOGY AND MOLECULAR BIOLOGY, UNIVERSITY OF HELSINKI ACADEMIC DISSERTATION

  2011cites this paper
• DNA damage-induced RORα is crucial for p53 stabilization and increased apoptosis.

  2011influential citation
• MOLECULAR STUDIES ON LIM-DOMAIN PROTEIN CRP1

  2011cites this paper
• World Journal of Gastrointestinal Pathophysiology

  year unknowncites this paper
• Association Between MDM 2 Promoter SNP 309 T / G Polymorphism and Liver Cancer Riska Meta-analysis

  year unknowncites this paper